BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25931304)

  • 1. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
    Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
    Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
    Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
    BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.
    Mogensen SS; Schmiegelow K; Grell K; Albertsen BK; Wehner PS; Kampmann P; Frandsen TL
    Haematologica; 2017 May; 102(5):e175-e178. PubMed ID: 28209659
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models.
    Al-Aridi C; Abboud MR; Saab R; Eid D; Jeha S; Chan AK; Muwakkit SA
    Pediatr Hematol Oncol; 2011 Nov; 28(8):676-81. PubMed ID: 21787123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
    Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
    Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catastrophic thromboembolism in a patient with acute lymphoblastic leukemia and hypereosinophilia.
    Williams E; Smart SC; Go RS
    Haematologica; 2004 Apr; 89(4):EIM01. PubMed ID: 15075104
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data].
    Baranova OIu; Shirin AD; Falaleeva NA; Osmanov DSh
    Ter Arkh; 2011; 83(7):26-32. PubMed ID: 21894748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
    Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
    Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism in children with cancer: a retrospective multicenter study in Korea.
    Choi HS; Kim HJ; Kang HJ; Lee JW; Shin HY; Park HJ; Park BK; Lee YH; Lee JA; Lim YJ; Park KD
    J Thromb Thrombolysis; 2019 May; 47(4):558-565. PubMed ID: 30666552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
    Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
    Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
    Te Winkel ML; Pieters R; Wind EJ; Bessems JH; van den Heuvel-Eibrink MM
    Haematologica; 2014 Mar; 99(3):430-6. PubMed ID: 24598854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.